Medication-Based Treatment to Address Opioid Use Disorder.
Publication
, Journal Article
Leshner, AI; Dzau, VJ
Published in: JAMA
June 4, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
June 4, 2019
Volume
321
Issue
21
Start / End Page
2071 / 2072
Location
United States
Related Subject Headings
- Stereotyping
- Opioid-Related Disorders
- Opiate Substitution Treatment
- Narcotic Antagonists
- Naltrexone
- Methadone
- Humans
- General & Internal Medicine
- Buprenorphine
- Analgesics, Opioid
Citation
APA
Chicago
ICMJE
MLA
NLM
Leshner, A. I., & Dzau, V. J. (2019). Medication-Based Treatment to Address Opioid Use Disorder. JAMA, 321(21), 2071–2072. https://doi.org/10.1001/jama.2019.5523
Leshner, Alan I., and Victor J. Dzau. “Medication-Based Treatment to Address Opioid Use Disorder.” JAMA 321, no. 21 (June 4, 2019): 2071–72. https://doi.org/10.1001/jama.2019.5523.
Leshner AI, Dzau VJ. Medication-Based Treatment to Address Opioid Use Disorder. JAMA. 2019 Jun 4;321(21):2071–2.
Leshner, Alan I., and Victor J. Dzau. “Medication-Based Treatment to Address Opioid Use Disorder.” JAMA, vol. 321, no. 21, June 2019, pp. 2071–72. Pubmed, doi:10.1001/jama.2019.5523.
Leshner AI, Dzau VJ. Medication-Based Treatment to Address Opioid Use Disorder. JAMA. 2019 Jun 4;321(21):2071–2072.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
June 4, 2019
Volume
321
Issue
21
Start / End Page
2071 / 2072
Location
United States
Related Subject Headings
- Stereotyping
- Opioid-Related Disorders
- Opiate Substitution Treatment
- Narcotic Antagonists
- Naltrexone
- Methadone
- Humans
- General & Internal Medicine
- Buprenorphine
- Analgesics, Opioid